James de Lemos

James de Lemos is Professor and Chief of Cardiology at UT Southwestern Medical Center. His research focuses on cardiovascular risk assessment, early disease detection, and biomarker applications, with leadership in the Dallas Heart Study—a multiethnic cohort of 6,000+ adults. He holds the Sweetheart Ball-Kern Wildenthal Distinguished Chair in Cardiology.

Research examines troponin applications, statin therapy outcomes, and cardiovascular risk stratification. Recent publications address troponin in endocarditis, statin-associated diabetes risk, and BNP in acute coronary syndromes.

Education includes summa cum laude BA from University of Texas at Austin, MD from Harvard Medical School, and residency/fellowship at UT Southwestern/Brigham and Women's Hospital. Key roles:

• J. Fred Schoellkopf Chair in Cardiology Research (2005-2009)
• Editorial boards: Circulation (Executive Editor), JACC, American Journal of Cardiology
• FDA Cardiorenal/Endocrine Advisory Panels
• ACC/AHA committee leadership

Honors include mentoring awards from AHA/ACC, teaching professorship, and association memberships. Current research involves COVID-19 CVD registry leadership and biomarker-guided therapy trials.